A new era in cancer therapeutics by developing personalised and targeted cancer treatments using the body's own immune system.
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.07.2024 | Seed | $7M | - |
Mentions in press and media 4
| Date | Title | Description |
| 12.07.2024 | Granza Bio: Revolutionizing Therapeutic Delivery with $7M+ in Seed Funding | Granza Bio, a cutting-edge therapeutic delivery platform company, has secured over $7 million in Seed funding to propel its groundbreaking work in the field of precision medicine. Led by Felicis and Refactor, with support from Y Combinator ... |
| 11.07.2024 | Granza Bio: Therapeutic Delivery Platform Company Closes Over $7 Million In Seed Funding | Therapeutic delivery platform company Granza Bio announced the closing of its oversubscribed $7.14 million Seed led by Felicis and Refactor, along with Y Combinator and notable angel investors. The funding round also includes participation ... |
| 04.07.2024 | Granza Bio Raises $7M+ in Seed Funding | Granza Bio, a San Francisco, CA-based therapeutic delivery platform developer, raised $7M+ in Seed funding.
The round was led by Felicis and Refactor, with participation from Y Combinator, Metaplanet, Zeno Ventures, Ritual Capital, Pioneer ... |
| - | Granza Bio | “granzabio.com” |
Reviews 0
